Pharmesis International Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 25.159 million compared to CNY 19.670 million a year ago. Operating income was CNY 412,000 compared to operating loss of CNY 3.427 million a year ago. Net loss was CNY 299,000 compared to CNY 3.670 million a year ago. Basic earnings per share from continuing operations was CNY 0.013 compared to CNY 0.16 a year ago.